U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
182821182821Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital PatientsRecruitingNo Results AvailableColonoscopyProcedure: Self-administered leaflethttps://ClinicalTrials.gov/show/NCT00160823
182822182822Outcome Study of Complex Distal Radius FracturesCompletedNo Results AvailableDistal Radius Fractureshttps://ClinicalTrials.gov/show/NCT00160810
182823182823Total Knee Arthroplasty Outcome StudyWithdrawnNo Results AvailableTotal Knee ReplacementDevice: MISâ„¢ Minimally Invasive Solutionsâ„¢ TKA Systemhttps://ClinicalTrials.gov/show/NCT00160797
182824182824Arthroscopy and Manipulation vs a Home Therapy Program in the Treatment of Adhesive CapsulitisCompletedNo Results AvailableAdhesive Capsulitis of the ShoulderProcedure: Arthroscopy|Procedure: Arthroscopic manipulation|Other: Home therapyhttps://ClinicalTrials.gov/show/NCT00160784
182825182825Biomechanics/Motion Analysis Laboratory Data BankRecruitingNo Results AvailableKinematicsBehavioral: Joint Motion Analysishttps://ClinicalTrials.gov/show/NCT00160771
182826182826Physical Characteristics of Retrieved Massive AllograftsCompletedNo Results AvailableBone CancerProcedure: retrieve massive allografthttps://ClinicalTrials.gov/show/NCT00160758
182827182827Rosuvastatin and Renal Endothelial FunctionCompletedNo Results AvailableHypercholesterolemiaDrug: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT00160745
182828182828Allogenic Islet Cell TransplantationActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 1Drug: Allogenic islet cells (human, U. Chicago)|Procedure: Intraportal infusion of islet cellshttps://ClinicalTrials.gov/show/NCT00160732
182829182829HLA Sensitization Following Major Cortical Allograft Bone ProceduresCompletedNo Results AvailableBone CancerProcedure: retrieve blood sampleshttps://ClinicalTrials.gov/show/NCT00160719
182830182830A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's DiseaseCompletedHas ResultsCrohn's DiseaseBiological: Certolizumab Pegol (CDP870)https://ClinicalTrials.gov/show/NCT00160706
182831182831Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisBiological: Certolizumab Pegolhttps://ClinicalTrials.gov/show/NCT00160693
182832182832ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)CompletedNo Results AvailableRhinitis, Allergic, PerennialDrug: Levocetirizinehttps://ClinicalTrials.gov/show/NCT00160680
182833182833A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)CompletedNo Results AvailableNeuralgia, PostherpeticDrug: Placebo|Drug: Brivaracetam|Drug: Brivaracetamhttps://ClinicalTrials.gov/show/NCT00160667
182834182834Open Label Safety and Efficacy Study of Levetiracetam in Patients With EpilepsyCompletedNo Results AvailableEpilepsy, PartialDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00160654
182835182835A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisBiological: Certolizumab Pegolhttps://ClinicalTrials.gov/show/NCT00160641
182836182836Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With EpilepsyCompletedNo Results AvailableEpilepsy, PartialDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00160628
182837182837Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label MethodCompletedNo Results AvailableEpilepsy, PartialDrug: levetiracetamhttps://ClinicalTrials.gov/show/NCT00160615
182838182838A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: Certolizumab Pegolhttps://ClinicalTrials.gov/show/NCT00160602
182839182839LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)CompletedNo Results AvailableRhinitis, Allergic, PerennialDrug: Levocetirizinehttps://ClinicalTrials.gov/show/NCT00160589
182840182840Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome DyskinesiasCompletedNo Results AvailableIdiopathic Parkinson DiseaseDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00160576
182841182841Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)TerminatedHas ResultsAsthmaDrug: LEVOCETIRIZINE|Other: Placebohttps://ClinicalTrials.gov/show/NCT00160563
182842182842Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic SeizuresCompletedNo Results AvailableGeneralized Convulsive EpilepsyDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00160550
182843182843POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNo Results AvailableSeasonal Allergic RhinitisDrug: Levocetirizinehttps://ClinicalTrials.gov/show/NCT00160537
182844182844A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]CompletedHas ResultsCrohn's DiseaseBiological: Certolizumab Pegol (CDP870)https://ClinicalTrials.gov/show/NCT00160524
182845182845A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)CompletedNo Results AvailableNeuralgia, PostherpeticDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00160511
182846182846Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese PatientsCompletedNo Results AvailableHypertensionDrug: Lercanidipinehttps://ClinicalTrials.gov/show/NCT00160498
182847182847Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational DiabetesWithdrawnNo Results AvailableGestational DiabetesDrug: Glyburide|Drug: Insulinhttps://ClinicalTrials.gov/show/NCT00160485
182848182848Evaluation of Vasopressin in the Vessels of Ovarian NeoplasmsCompletedNo Results AvailableOvarian NeoplasmsProcedure: removal of ovarian vesselshttps://ClinicalTrials.gov/show/NCT00160472
182849182849A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine FibroidsCompletedNo Results AvailableLeiomyomaDrug: Asoprisnil|Drug: Asoprisnil|Drug: Asoprisnil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00160459
182850182850A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With EndometriosisCompletedNo Results AvailableEndometriosisDrug: Asoprisnil|Drug: Asoprisnil|Drug: Asoprisnil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00160446

* Görseller ve İçerik tekif hakkına sahip olabilir